Aurinia Pharmaceuticals Inc (AUPH)

[puravida]

ahhh the classic suspense reminds me to those ariad days. I love the poster's comments about missing 2da's intense manifesto posts. I remember those Aurinia knows what it owns and after Aurora-2 updates the data don't lie. Just like Tim Clackson reporting the ph3 Brigatinib NSCLC late 2016...after that we all knew what Ariad owned. In fact, now Brig is also FDA approved for First Line therapy since it was initially FDA approved after the Takeda deal later in 2017. The suitor knows it can extract more value out of purchasing a young high quality asset

Since AUPH knows the potential with Lupkynis I do believe the deal will happen. but not immediately. I recall Harvey Berger saying he couldn't believe it took as long as it did for Denner to seal the deal. Thats M&A for ya...I think these deals take longer than planned most of the time, especially when young, high quality drugs like Lupkynis are potentially up for sale

I think this company gets sold for $35-47 a share with potential CVRs.

Folks concerned that AUPH PR'd their attendance to Jefferies Conf Nov 18th should also reflect back to good ole ARIAD They too PR'd their attendance to JP Morgan Health Care Conf, way more prestigious than a corporate update at Jefferies etc. that PR was issued in December 2016. Per SEC filings of the ARIA buyout, offers were rejected and re-offered to Paris P around 12/25/16 and final $24/share accepted. Attendance to JP Morgan and presentation was still in tact. It wasn't until Jan 9 2017 that we woke up to finding out about this deal being official!. Immediately after theARIA presentation at JP Morgan was canceled ! My point is I don't look at any PR's stating AUPH attending a conference impacts the flow of any deals. If AUPH is sold tomorrow. we will know